Umbilical cord as a mesenchymal stem cell source for treating joint pathologies

doi:10.5312/wjo.v2.i6.43

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5945)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

541

HTML

4914

Figures (1-3)

490

Sum=5945

Jun 18, 2011 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Orthop. Jun 18, 2011; 2(6): 43-50
Published online Jun 18, 2011. doi: 10.5312/wjo.v2.i6.43

Full Size Figure Download Figure

Figure 2 Representative diagrams of the methodology for spheroid chondrogenesis. Diagram showing culture times used for a new method for the induction of chondrogenesis. Representative sections of immunohistochemical analyses for collagen type 2 (COL2) expression from spheroids engineered from Wharton´s jelly mesenchymal stem cells at different times of chondrogenesis are shown. (Magnification 10x). AA: Ascorbic acid; MTG: Monothioglycerol; RA: Retinoic acid; KO serum: Knock out serum (GIBCO™); TGFβ-3: Recombinant human transforming growth factor-β3; TRANS: Transferrine; DEX: Dexamethasone.

Citation: Arufe MC, Fuente ADL, Fuentes I, Toro FJD, Blanco FJ. Umbilical cord as a mesenchymal stem cell source for treating joint pathologies. World J Orthop 2011; 2(6): 43-50
URL: https://www.wjgnet.com/2218-5836/full/v2/i6/43.htm
DOI: https://dx.doi.org/10.5312/wjo.v2.i6.43